文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,358+ SCI 论文 与阿拉丁产品引用相关
2,303,472.95 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

3 项

设置提升方向
泮托拉唑
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES · 2018 · IF 2.441

Rapid determination of 3′, 4′-dimethoxy flavonol-3-β-d-glucopyranoside in rat plasma by LC-MS/MS method followed by protein precipitation

Qiong Lou,Jun Wen,Yuanying Jiang,Jinghua Huang,Guorong Fan,Fenyun Song

A reliable liquid chromatography/tandem mass (LC-MS/MS) method was developed for quantitation of 3′, 4′-dimethoxy flavonol-3-β- d -glucopyranoside (DF3G) in rat plasma using pantoprazole as the internal standard. An Agilent C18 column (100 mm × 3 mm, 3.5 μm) was performed for chromatographic separation with the mobile phase composed of methanol-water (containing formic acid) at a flow rate of 0.4 mL/min. A triple-quadrupole mass spectrometry equipped with an electrospray ionization (ESI) source in positive ion mode was applied to quantitative analysis by multiple reacting monitoring (MRM). The MRM precursor-product ion transition of DF3G and Pantoprazole (IS) were m / z 461.1 → 299.2 and 383.9 → 200.2, respectively. Calibration curves were recovered in a concentration range of 1–500 ng/mL for plasma with a limit of lower quantification (LLOQ) of 1 ng/mL. The intra-day and inter-day precision were not >10%. The accuracy of DF3G ranged from −10% to 0.53% in quality control (QC) samples at three concentrations. DF3G was not degraded during the analysis and the storage period. All the data were validated in accordance with the FDA bioanalytical method validation guideline. The LC-MS/MS method was successfully employed in the pharmacokinetic study of the DF3G after oral administration and intravenous injection in rats.

CAS / MDL: 102625-70-7
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Applied Materials & Interfaces · 2025 · IF 8.2

Microphase Structure and Component Influence on Drug Sorption: Polyurethane-Drug Interaction Elucidation in Medical Catheter Systems

Lin Tang,Ao Wang,Hecheng Wu,Wenkai Liu,Feng Luo,Jiehua Li,Zhen Li,Hong Tan

Polyurethanes are predominant materials for medical catheter manufacturing owing to their favorable physicochemical properties and biocompatibility. However, the drug-polyurethane interactions compromise therapeutic infusion efficacy and restrict its application in intravenous tubing. There are gaps in systematic research on sorption mechanisms pertaining to polyurethane infusion systems. This study investigates the structure–sorption relationship between polyurethane and active pharmaceutical ingredients (APIs), through combined investigations of dynamic sorption kinetics, static equilibrium sorption, and molecular dynamics simulations. It was revealed that enhanced molecular interactions in highly microphase-mixing polyurethanes reduced the free volume, thereby decreasing drug diffusion rates. The API sorption process exhibits three-stage Fickian diffusion behaviors. Equilibrium drug sorption concentration and equilibrium drug sorption capacity can be calculated from the initial drug concentration. Freundlich constant (Kf) and partition coefficient (K) effectively represent the drug sorption capacity. Molecular dynamics simulations further quantify binding energetics, identifying Lennard–Jones short-range (LJ-SR) interactions as the predominant driver of drug-polymer adhesion. These findings provide insights for optimizing polyurethane formulations to minimize drug sorption and maintain therapeutic efficacy.

CAS / MDL: 102625-70-7 66085-59-4
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Bioactive Materials · 2025 · IF 20.3

Real-time magnetic resonance visualization of tumor acidosis as a precognition indicator of therapeutic efficacy

Mengyao Mu,Mengmeng Zhang,Jie Liu,Ke Ren,Hui Liu,Lixian Yip,Kai Guo,Feifei Teng,Jian Dong,Xueli Xu,David Tai Leong,Xiao Sun

Traditional antitumor strategies often require sufficient time to assess the effectiveness according to changes in tumor structure. Once ineffective, patients may miss the critical window for pursuing alternative treatment options. Herein, a manganese sulfide nanoplatform loaded with proton pump inhibitor (PPI) is developed. This nanoplatform is designed for visualizing tumor acidosis degree by magnetic resonance imaging (MRI), achieving real-time therapeutic efficacy precognition. The nanoplatform releases PPI, H 2 S, and Mn 2+ within the acidic lysosome of tumor cells. PPI inhibits V-ATPase expression, leading to an increase in intracellular H + levels. H 2 S accelerates glucose consumption of tumor cells, producing more lactic acid and further inducing tumor acidosis. Tumor acidosis in turn accelerates the nanoplatform's degradation, achieving higher tumor MRI. As the tumor acidosis degree correlates positively with tumor regression, real-time visualization of acidosis degree effectively predicts future therapeutics. Interestingly, tumor acidosis achieves efficient tumor metastasis suppression rather than increases it. Overall, this work presents a nanoplatform capable of visualizing tumor acidosis in real-time and precisely predicting future therapeutics.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。